AI-Assisted Bioinformatics
Machine learning-enabled workflows for biomarker discovery, variant prioritization, and predictive genomics.
In-Silico Drug Discovery
Target Identification & Structure-Based Design
AI-Powered Multi-Omics Target Discovery, Structural Biology & Druggability Assessment
RASA Life Science Informatics provides advanced Target Identification & Structure-Based Design services that integrate multi-omics analytics, systems biology, structural bioinformatics, and artificial intelligence to accelerate early-stage drug discovery.
Our platform combines genomics, transcriptomics, proteomics, network biology, machine learning, and protein structure modeling to identify, prioritize, and characterize high-confidence therapeutic targets across oncology, neuroscience, infectious diseases, autoimmune disorders, metabolic diseases, and rare disorders.
Using industry-leading technologies such as AlphaFold, STRING, Reactome, Open Targets, DisGeNET, and DrugBank, we evaluate targets based on biological relevance, disease association, pathway involvement, structural tractability, and druggability potential. These insights support downstream applications including molecular docking, virtual screening, molecular dynamics simulations, and structure-based drug design.
Service Offerings
What We Offer
Multi-Omics Target Discovery
- ✓Genomics, transcriptomics, and proteomics integration
- ✓Differential expression analysis
- ✓Biomarker identification
- ✓Pathway enrichment analysis
AI-Powered Knowledge Mining
- ✓Literature mining using NLP and AI
- ✓Gene–disease association discovery
- ✓Evidence-based target prioritization
Protein Structure Modeling
- ✓AlphaFold structure prediction
- ✓Homology modeling and refinement
- ✓Structural validation
- ✓Functional domain characterization
Druggability Assessment
- ✓Binding pocket identification
- ✓Active site characterization
- ✓Ligandability assessment
- ✓Structural tractability analysis
Target Prioritization
- ✓Disease relevance scoring
- ✓Novelty and essentiality assessment
- ✓Safety and selectivity evaluation
- ✓Clinical evidence integration
Capabilities
Key Features
✓Integrated Discovery-to-Design Workflow
✓AI-Assisted Target Identification & Prioritization
✓Advanced Structural Bioinformatics
✓Multi-Omics & Systems Biology Integration
✓Cloud-Ready, Reproducible Pipelines
Sectors
Applications
Oncology Drug DiscoveryPrecision Medicine ProgramsRare Disease ResearchNeurodegenerative Disease ResearchDrug Repurposing StudiesStructure-Based Drug Design
Technology
Technologies & Databases
Biological Databases
Open Targets
DrugBank
ChEMBL
DisGeNET
TCGA
GTEx
GEO
Structural Biology
AlphaFold
I-TASSER
SWISS-MODEL
PDB
Network Biology
STRING
Cytoscape
Reactome
KEGG
Infrastructure & Pipelines
Nextflow
Snakemake
Docker
AWS
Google Cloud
HPC Clusters
Why RASA
Why Choose RASA?
Multi-Platform Expertise
Support for Illumina, Oxford Nanopore, PacBio HiFi, and 10x Genomics platforms.
End-to-End Analysis
From raw sequencing data to biological interpretation and publication-ready reports.
Cloud-Ready Infrastructure
Deployable on AWS, Google Cloud, HPC clusters, and secure on-premise environments.
Reproducible Workflows
Built using Nextflow, Snakemake, Docker, and Singularity for enterprise-grade bioinformatics operations.
Ready to partner with a trusted bioinformatics company in India?
Get in touch with our team in Pune, India to discuss sample sizes, platform details, and custom bioinformatics pipeline configurations for your research program.
Start a Project